Deborah Blum Awarded Endocrine Society Award for Excellence in Science and Medical Journalism

Deborah Blum headshot

MIT Knight Science Journalism Program Director and Undark Magazine publisher Deborah Blum received the Endocrine Society’s annual Award for Excellence in Science and Medical Journalism.

Blum was honored for her coverage of the health effects soy milk and formula have on infants. The winning article, “The Great Soy Formula Experiment,” was published in Undark Magazine in August 2017.

In her article, Blum examines how natural compounds in soy can interfere with estrogen hormones in the body and affect reproductive health. Compounds called phytoestrogens found in soy can act as an endocrine-disrupting chemical (EDC). Research has found EDC exposure is associated with a number of health problems, including male reproductive disorders, premature death, obesity and diabetes, neurological impacts, breast cancer, endometriosis, female reproductive disorders, immune disorders, liver cancer, osteoporosis, Parkinson’s disease, prostate cancer, and thyroid disorders.

Blum is a Pulitzer Prize-winning science journalist, columnist, and author of five books, including The Poisoner’s Handbook and Love at Goon Park. She is a former president of the National Association of Science Writers, was a member of the governing board of the World Federation of Science Writers, and currently serves as vice president of the Council for the Advancement of Science Writing. Blum is co-editor of the book A Field Guide for Science Writers. In 2015, she was selected as the fourth director of the Knight Science Journalism Program at MIT.

The Society established the journalism award in 2008 to recognize outstanding reporting that enhances the public understanding of health issues pertaining to the field of endocrinology.

More information on the Endocrine Society Award for Excellence in Science and Medical Journalism is available at: https://www.endocrine.org/news-room/journalism-award.

You may also like

  • Individuals Taking Class of Steroid Medications at High Risk for COVID-19

    JCEM Editors examine pandemic’s impact on endocrine patients in editorial Individuals taking a class of steroid hormones called glucocorticoids for conditions such as asthma, allergies and arthritis on a routine basis may be unable to mount a normal stress response and are at high risk if they are infected with the virus causing COVID-19, according…

  • Endocrine Society Elects Wysham as 2021-2022 President

    Five endocrinologists to join Board of Directors Endocrine Society members have elected Carol H. Wysham, MD, to serve as the organization’s President for the 2021-2022 term. Wysham is an endocrinologist at Rockwood/MultiCare Health Systems in Spokane, Wash., and Clinical Professor of Medicine at the University of Washington. She will serve as President-Elect for a year…

Find more in